Invictus MD Strategies Corp.
IVITF
Other OTC0.00
USD
+0.00
- -
Invictus MD Strategies Corp.
IVITF
(Other OTC)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Invictus MD Strategies Corp is a Canada-based cannabis company primarily engaged in the investment, acquisition, and development of synergistic businesses within the medical and recreational cannabis sector. Founded in 2014 and headquartered in White Rock, British Columbia, Invictus operates two fully licensed medical cannabis production facilities under the Access to Cannabis for Medical Purposes Regulations (ACMPR) in Canada, with a third facility pending approval. The company offers a diversified portfolio of over 69 Health Canada-approved cannabis strains marketed under four lifestyle brands—Dukes, Zooey, Sterling & Hunt, and Sinister—targeting both medical and adult-use consumers. In addition to cannabis cultivation and product manufacturing, Invictus produces fertilizers and nutrients through its subsidiary Future Harvest Development Ltd., which supports consistent quality and supply. Invictus deploys a multifaceted distribution strategy encompassing medical sales, adult-use recreational cannabis, international markets, Licensed Producer to Licensed Producer partnerships, and retail store channels. Recent strategic developments include a significant partnership with the Ontario Cannabis Store to supply recreational cannabis products and the acquisition of Leaf Wise, a medical clinic operator serving approximately 3,400 ACMPR-registered patients, enhancing direct access to its licensed cannabis products. The company has also launched a new medical cannabis brand, T2C, in partnership with Authentic Brands Group, supported by a $500,000 marketing campaign to increase brand awareness across North America. Additionally, Invictus has strengthened its management team through strategic hires to scale operations and drive investor relations. Invictus continues to expand its cultivation footprint, with planned scale-up from 100,000 square feet to an expected 1 million square feet of grow space by the end of 2025, positioning the company to meet growing market demand. Its wholly-owned subsidiary Acreage Pharms Ltd. is developing purpose-built facilities designed to meet European Union Good Manufacturing Practices (EU-GMP) standards, aimed at increasing international medical cannabis sales. The company leverages integrated technology platforms to foster product innovation and performance across its supply chain. This multi-pronged growth strategy reflects Invictus's objective of becoming a leading diversified cannabis entity within Canada and internationally.